Vitasora Health Limited (ASX:VHL)
Australia
· Delayed Price · Currency is AUD 0.0200
-0.0030 (-13.04%)
Mar 10, 2026, 12:29 PM AEST
Vitasora Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 4.46 | 3.09 | 0.46 | 0.07 | 0.25 | 0.27 | Upgrade
|
| Other Revenue | 0.55 | 0.61 | 0.58 | 0.59 | 0.52 | 1.12 | Upgrade
|
| Revenue | 5.01 | 3.71 | 1.04 | 0.66 | 0.77 | 1.39 | Upgrade
|
| Revenue Growth (YoY) | 170.30% | 256.78% | 56.85% | -14.26% | -44.29% | -35.69% | Upgrade
|
| Cost of Revenue | -0.2 | 0.03 | 0 | 0.07 | 0.26 | 1.26 | Upgrade
|
| Gross Profit | 5.21 | 3.68 | 1.03 | 0.6 | 0.51 | 0.12 | Upgrade
|
| Selling, General & Admin | 14.8 | 12.31 | 7.36 | 5.57 | 5.29 | 7.22 | Upgrade
|
| Research & Development | 0.15 | 0.24 | 0.14 | 0.38 | 1.46 | 1.39 | Upgrade
|
| Operating Expenses | 16.8 | 13.78 | 8.1 | 6.36 | 7.14 | 11.21 | Upgrade
|
| Operating Income | -11.59 | -10.1 | -7.06 | -5.76 | -6.63 | -11.09 | Upgrade
|
| Interest Expense | - | - | -0.07 | -0.02 | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.05 | Upgrade
|
| Pretax Income | -11.59 | -10.1 | -7.13 | -5.78 | -6.62 | -11.04 | Upgrade
|
| Income Tax Expense | 0 | 0 | - | - | - | - | Upgrade
|
| Net Income | -11.59 | -10.11 | -7.13 | -5.78 | -6.62 | -11.04 | Upgrade
|
| Net Income to Common | -11.59 | -10.11 | -7.13 | -5.78 | -6.62 | -11.04 | Upgrade
|
| Shares Outstanding (Basic) | 1,660 | 1,396 | 1,018 | 806 | 729 | 699 | Upgrade
|
| Shares Outstanding (Diluted) | 1,660 | 1,396 | 1,018 | 806 | 729 | 699 | Upgrade
|
| Shares Change (YoY) | 41.69% | 37.16% | 26.19% | 10.68% | 4.23% | 22.63% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Free Cash Flow | -10.79 | -9.17 | -6.64 | -4.51 | -8.48 | -7.39 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 103.94% | 99.19% | 99.63% | 90.09% | 66.42% | 8.84% | Upgrade
|
| Operating Margin | -231.37% | -272.69% | -680.22% | -870.00% | -858.74% | -800.27% | Upgrade
|
| Profit Margin | -231.39% | -272.73% | -686.48% | -872.26% | -857.85% | -796.57% | Upgrade
|
| Free Cash Flow Margin | -215.35% | -247.43% | -639.50% | -681.46% | -1098.15% | -533.43% | Upgrade
|
| EBITDA | -11.53 | -10.04 | -7 | -5.75 | -6.62 | -11.08 | Upgrade
|
| EBITDA Margin | -230.20% | -271.09% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.06 | 0.06 | 0.06 | 0.01 | 0.02 | 0.01 | Upgrade
|
| EBIT | -11.59 | -10.1 | -7.06 | -5.76 | -6.63 | -11.09 | Upgrade
|
| EBIT Margin | -231.37% | -272.69% | - | - | - | - | Upgrade
|
| Revenue as Reported | 3.71 | 3.71 | 1.04 | 0.66 | 0.78 | 1.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.